<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/ms2025-299</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-9365</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>РЕВМАТОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>RHEUMATOLOGY</subject></subj-group></article-categories><title-group><article-title>Особенности длительного течения системной красной волчанки (клиническое наблюдение и обзор литературы)</article-title><trans-title-group xml:lang="en"><trans-title>Specific aspects of the long-term course of systemic lupus erythematosus (clinical observation and literature review)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2694-6614</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ракитская</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Rakitskaya</surname><given-names>I V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ракитская Ирина Валериевна, к.м.н., доцент, доцент кафедры терапии им. проф. А.И. Дядыка факультета непрерывного медицинского и фармацевтического образования</p><p>283003, Донецк, проспект Ильича, д. 16</p></bio><bio xml:lang="en"><p>Irina V. Rakitskaya, Cand. Sci. (Med.), Associate Professor, Associate Professor of Therapy Department named after Prof. A.I. Dyadyk, Faculty of Continuing Medical and Pharmaceutical Education</p><p>16, Ilyicha Ave., Donetsk, 283003</p></bio><email xlink:type="simple">rakytskaya@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3984-8482</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тарадин</surname><given-names>Г. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Taradin</surname><given-names>G. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Тарадин Геннадий Геннадьевич, к.м.н., доцент, заведующий кафедрой терапии им. проф. А.И. Дядыка факультета непрерывного медицинского и фармацевтического образования,</p><p>283003, Донецк, проспект Ильича, д. 16</p></bio><bio xml:lang="en"><p>Gennady G. Taradin, Cand. Sci. (Med.), Associate Professor, Head of Therapy Department named after Prof. A.I. Dyadyk, Faculty of Continuing Medical and Pharmaceutical Education</p><p>16, Ilyicha Ave., Donetsk, 283003</p></bio><email xlink:type="simple">taradin@inbox.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0295-3724</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Багрий</surname><given-names>A. Э.</given-names></name><name name-style="western" xml:lang="en"><surname>Bagriy</surname><given-names>A. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Багрий Андрей Эдуардович, д.м.н., профессор, заведующий кафедрой внутренних болезней №2, проректор по последипломному образованию и региональному развитию здравоохранения</p><p>283003, Донецк, проспект Ильича, д. 16</p></bio><bio xml:lang="en"><p>Andrey E. Bagriy, Dr. Sci (Med.), Professor, Head of the Department of Internal Medicine No. 2, Vice-Rector for Postgraduate Education and Regional Healthcare Development, Faculty of Continuing Medical and Pharmaceutical Education</p><p>16, Ilyicha Ave., Donetsk, 283003</p></bio><email xlink:type="simple">bagriyae@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0009-3901-3611</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Яровая</surname><given-names>Н. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Yarovaya</surname><given-names>N. F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Яровая Наталья Федоровна, к.м.н., доцент, доцент кафедры терапии им. проф. А.И. Дядыка факультета непрерывного медицинского и фармацевтического образования</p><p>283003, Донецк, проспект Ильича, д. 16</p></bio><bio xml:lang="en"><p>Natalya F. Yarovaya, Cand. Sci. (Med.), Associate Professor, Associate Professor of Therapy Department named after Prof. A.I. Dyadyk, Faculty of Continuing Medical and Pharmaceutical Education</p><p>16, Ilyicha Ave., Donetsk, 283003</p></bio><email xlink:type="simple">nyarovaja@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0009-0227-747X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Скорик</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Skorik</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Скорик Алена Витальевна, ординатор по специальности 31.08.36 «Кардиология» кафедры терапии им. проф. А.И. Дядыка факультета непрерывного медицинского и фармацевтического образования</p><p>283003, Донецк, проспект Ильича, д. 16</p></bio><bio xml:lang="en"><p>Alena V. Skorik, Resident in Specialty 31.08.36 Cardiology Therapy Department named after Prof. A.I. Dyadyk, Faculty of Continuing Medical and Pharmaceutical Education</p><p>16, Ilyicha Ave., Donetsk, 283003</p></bio><email xlink:type="simple">alenavitaljevnaivzhenko@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0005-4560-2632</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кононенко</surname><given-names>Л. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kononenko</surname><given-names>L. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кононенко Людмила Викторовна, ассистент кафедры терапии им. проф. А.И. Дядыка факультета непрерывного медицинского и фармацевтического образования</p><p>283003, Донецк, проспект Ильича, д. 16</p></bio><bio xml:lang="en"><p>Lyudmila V. Kononenko, Assistante of Therapy Department named after Prof. A.I. Dyadyk, Faculty of Continuing Medical and Pharmaceutical Education</p><p>16, Ilyicha Ave., Donetsk, 283003</p></bio><email xlink:type="simple">liudmilavikkononenko@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6219-7537</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хоменко</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Homenko</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Хоменко Марина Владимировна, к.м.н., доцент, доцент кафедры терапии им. проф. А.И. Дядыка факультета непрерывного медицинского и фармацевтического образования</p><p>283003, Донецк, проспект Ильича, д. 16</p></bio><bio xml:lang="en"><p>Marina V. Homenko, Cand. Sci. (Med.), Associate Professor, Associate Professor of Therapy Department named after Prof. A.I. Dyadyk, Faculty of Continuing Medical and Pharmaceutical Education</p><p>16, Ilyicha Ave., Donetsk, 283003</p></bio><email xlink:type="simple">mv.homenko@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6416-2899</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Стрионова</surname><given-names>В. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Strionova</surname><given-names>V. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Стрионова Вера Сергеевна, к.м.н., доцент кафедры детской хирургии и анестезиологии</p><p>283003, Донецк, проспект Ильича, д. 16</p></bio><bio xml:lang="en"><p>Vera S. Strionova, Cand. Sci. (Med.), Associate Professor of the Department of Pediatric Surgery and Anesthesiology</p><p>16, Ilyicha Ave., Donetsk, 283003</p></bio><email xlink:type="simple">vera.strionova@bk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Донецкий государственный медицинский университет имени М. Горького</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Donetsk State Medical University named after M. Gorky</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>10</day><month>09</month><year>2025</year></pub-date><volume>19</volume><issue>13</issue><fpage>200</fpage><lpage>211</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ракитская И.В., Тарадин Г.Г., Багрий A.Э., Яровая Н.Ф., Скорик А.В., Кононенко Л.В., Хоменко М.В., Стрионова В.С., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Ракитская И.В., Тарадин Г.Г., Багрий A.Э., Яровая Н.Ф., Скорик А.В., Кононенко Л.В., Хоменко М.В., Стрионова В.С.</copyright-holder><copyright-holder xml:lang="en">Rakitskaya i.V., Taradin G.G., Bagriy A.E., Yarovaya N.F., Skorik A.V., Kononenko L.V., Homenko M.V., Strionova V.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/9365">https://www.med-sovet.pro/jour/article/view/9365</self-uri><abstract><p>Системная красная волчанка (СКВ) – системное аутоиммунное заболевание с мультисистемными проявлениями и вариабельным характером течения. В статье представлено наблюдение за течением СКВ на протяжении 15 лет у мужчины, которому СКВ диагностировали в возрасте 37 лет после годичного периода выраженного суставного синдрома, что явилось основанием первоначально предположить ревматоидный артрит. Спустя год после манифестации суставного синдрома у больного клиническая картина СКВ была представлена кардитом (пароксизмы узловой тахикардии), иммунологическими (LE-клетки, антитела к нативной ДНК и антикардиолипину) и гематологическими нарушениями (анемия, лейкопения, тромбоцитопения), алопецией, волчаночным нефритом с нефротическим синдромом и антифосфолипидным синдромом (тромбоз почечной вены). Во время последнего обследования при выполнении эхокардиографического исследования были выявлены признаки клапанной болезни сердца: утолщение створок митрального и аортального клапанов, что, возможно, обусловлено собственно волчаночным процессом и антифосфолипидным синдромом. За весь период течение заболевания характеризовалось чередованием периодов обострения и ремиссии активности волчаночного процесса (рецидивирующе-ремитирующий вариант). Больной все это время находился на поддерживающей иммуносупрессивной терапии (метилпреднизолон, циклофосфан). Уровни активности СКВ, определяемые по индексу SLEDAI-2K на моменты госпитализаций пациента, оценивались как высокий и очень высокий. Если в первые годы заболевания поражение почек проявлялось нефротическим синдромом, то в последние 5 лет волчаночный нефрит протекал с изолированным мочевым синдромом. Во время последней госпитализации при проведении эхокардиографического исследования выявлены признаки клапанной болезни сердца с утолщением створок митрального и аортального клапана с умеренной митральной недостаточностью. В статье анализируется собственный опыт длительного наблюдения за больным СКВ с обсуждением литературных данных, посвященных клиническим проявлениям заболевания.</p></abstract><trans-abstract xml:lang="en"><p>Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with multisystem manifestations and a variable course. The article presents an observation of the course of SLE for 15 years in a male who was diagnosed with SLE at the age of 37 after a one-year period of severe joint syndrome, which was the reason to initially suggest “rheumatoid arthritis.” A year after the manifestation of the joint syndrome in the patient, the clinical picture of SLE was presented by carditis (paroxysms of nodal tachycardia), immunological (LE-cells, antibodies to native DNA and anticardiolipin), hematological abnormalities (anemia, leukopenia, thrombocytopenia), alopecia, lupus nephritis with nephrotic syndrome and antiphospholipid syndrome (renal vein thrombosis). During the last hospital admission, echocardiographic examination revealed signs of valvular heart disease: thickening of the leaflets of the mitral and aortic valves, which may be due to the lupus process itself and antiphospholipid syndrome. The patient was observed in the clinic for 15 years. During the entire period of the disease, the course was characterized by alternating periods of flares and remissions of the activity of the lupus process (relapsing-remitting variant). The patient was on supportive immunosuppressive therapy (methylprednisolone, cyclophosphamide) all this time. The levels of SLE activity, determined by the SLEDAI-2K index at the time of the patient’s admissions, were assessed as high and very high ones. If in the early years of the disease kidney damage was manifested by nephrotic syndrome, then in the last 5 years lupus nephritis has occurred with isolated urinary syndrome. During the last hospitalization, echocardiographic examination revealed signs of valvular heart disease with leaflet thickening of the mitral and aortic valves with moderate mitral insufficiency. The article analyzes authors’ experience of long-term follow-up of SLE patients with a discussion of the literature data on the clinical features of the disease.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>миокардит</kwd><kwd>волчаночный нефрит</kwd><kwd>нефротический синдром</kwd><kwd>антифосфолипидный синдром</kwd><kwd>клапанная болезнь сердца</kwd><kwd>активность</kwd></kwd-group><kwd-group xml:lang="en"><kwd>myocarditis</kwd><kwd>lupus nephritis</kwd><kwd>nephrotic syndrome</kwd><kwd>antiphospholipid syndrome</kwd><kwd>valvular heart disease</kwd><kwd>activity</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78(9):1151–1159. https://doi.org/10.1136/annrheumdis-2018-214819.</mixed-citation><mixed-citation xml:lang="en">Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78(9):1151–1159. https://doi.org/10.1136/annrheumdis-2018-214819.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Игнатенко ГА, Ракитская ИВ, Тарадин ГГ, Христуленко АЛ, Куглер ТЕ. Современные представления о системной красной волчанке: акценты на диагностику и лечение. Университетская клиника. 2022;(3):105–117. Режим доступа: http://journal.dnmu.ru/index.php/UC/article/view/887.</mixed-citation><mixed-citation xml:lang="en">Ignatenko GA, Rakitskaya IV, Taradin GG, Khristulenko AL, Kugler TE. Current concepts about systemic lupus erythematosus: accents on diagnosis and treatment. Universitetskaja Klinika. 2022;(3):105–117. (In Russ.) Available at: http://journal.dnmu.ru/index.php/UC/article/view/887.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Насонов ЕЛ, Соловьев СК, Аршинов АВ. Системная красная волчанка: история и современность. Научно-практическая ревматология. 2022;60(4):397–412. https://doi.org/10.47360/1995-4484-2022-397-412.</mixed-citation><mixed-citation xml:lang="en">Nasonov EL, Soloviev SK, Arshinov AV. Systemic lupus erythematosus: history and modernity. Rheumatology Science and Practice. 2022;60(4):397–412. (In Russ.) https://doi.org/10.47360/1995-4484-2022-397-412.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Siegel CH, Sammaritano LR. Systemic lupus erythematosus: a review. JAMA. 2024;331(17):1480–1491. https://doi.org/10.1001/jama.2024.2315.</mixed-citation><mixed-citation xml:lang="en">Siegel CH, Sammaritano LR. Systemic lupus erythematosus: a review. JAMA. 2024;331(17):1480–1491.  https://doi.org/10.1001/jama.2024.2315.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Nikfar M, Malek Mahdavi A, Khabbazi A, Hajialilo M. Long-term remission in patients with systemic lupus erythematosus. Int J Clin Pract. 2021;75(4):e13909. https://doi.org/10.1111/ijcp.13909.</mixed-citation><mixed-citation xml:lang="en">Nikfar M, Malek Mahdavi A, Khabbazi A, Hajialilo M. Long-term remission in patients with systemic lupus erythematosus. Int J Clin Pract. 2021;75(4):e13909. https://doi.org/10.1111/ijcp.13909.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Connelly K, Morand EF. Systemic lupus erythematosus: a clinical update. Intern Med J. 2021;51(8):1219–1228. https://doi.org/10.1111/imj.15448.</mixed-citation><mixed-citation xml:lang="en">Connelly K, Morand EF. Systemic lupus erythematosus: a clinical update. Intern Med J. 2021;51(8):1219–1228. https://doi.org/10.1111/imj.15448.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Асеева ЕА, Соловьев СК, Попкова ТВ, Никишина НЮ, Меснянкина АА. Ведение пациентов с системной красной волчанкой в реальной клинической практике. Научно-практическая ревматология. 2019;57(2):191–196. https://doi.org/10.14412/1995-4484-2019-191-196.</mixed-citation><mixed-citation xml:lang="en">Aseeva EA, Soloviev SK, Popkova TV, Nikishina NYu, Mesnyankina AA. Management of patients with systemic lupus erythematosus in real clinical practice. Rheumatology Science and Practice. 2019;57(2):191–196. (In Russ.) https://doi.org/10.14412/1995-4484-2019-191-196.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Моисеев СВ, Новиков ПИ, Буланов НМ. Системная красная волчанка: эпидемиология, отдаленные исходы бремя болезни. Клиническая фармакология и терапия. 2021;30(4):13–22. https://doi.org/10.32756/0869-5490-2021-4-13-22.</mixed-citation><mixed-citation xml:lang="en">Moiseev S, Novikov P, Bulanov N. Systemic lupus erythematosus: epidemiology, outcomes and burden. Clinical Pharmacology and Therapy. 2021;30(4):13–22. (In Russ.) https://doi.org/10.32756/0869-5490-2021-4-13-22.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Gladman DD et al. Mortality in systemic lupus erythematosus. Arthritis Rheum. 2006;54(8):2550–2557. https://doi.org/10.1002/art.21955.</mixed-citation><mixed-citation xml:lang="en">Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Gladman DD et al. Mortality in systemic lupus erythematosus. Arthritis Rheum. 2006;54(8):2550–2557. https://doi.org/10.1002/art.21955.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Fors Nieves CE, Izmirly PM. Mortality in systemic lupus erythematosus: an updated review. Curr Rheumatol Rep. 2016;18(4):21. https://doi.org/10.1007/s11926-016-0571-2.</mixed-citation><mixed-citation xml:lang="en">Fors Nieves CE, Izmirly PM. Mortality in systemic lupus erythematosus: an updated review. Curr Rheumatol Rep. 2016;18(4):21. https://doi.org/10.1007/s11926-016-0571-2.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Лазарева НВ, Бугрова ОВ, Артемова НЭ, Нагорнова КА. Выживаемость и структура летальных исходов в оренбургской популяции пациентов с системной красной волчанкой. Современная ревматология. 2024;18(3):44–51. https://doi.org/10.14412/1996-7012-2024-3-44-51.</mixed-citation><mixed-citation xml:lang="en">Lazareva NV, Bugrova OV, Artemova NE, Nagornova KA. Survival and lethal outcomes in Orenburg population of patients with systemic lupus erythematosus. Sovremennaya Revmatologiya. 2024;18(3):44–51. (In Russ.) https://doi.org/10.14412/1996-7012-2024-3-44-51.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Smiley A, Matinfar M, Fatemi A. Long-term follow-up of Iranian male patients with systemic lupus erythematosus. Clin Exp Med. 2023;23(7):3399–3406. https://doi.org/10.1007/s10238-022-00986-y.</mixed-citation><mixed-citation xml:lang="en">Smiley A, Matinfar M, Fatemi A. Long-term follow-up of Iranian male patients with systemic lupus erythematosus. Clin Exp Med. 2023;23(7):3399–3406.   https://doi.org/10.1007/s10238-022-00986-y.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Tamirou F, Arnaud L, Talarico R, Scirè CA, Alexander T, Amoura Z et al. Systemic lupus erythematosus: state of the art on clinical practice guidelines. RMD Open. 2018;4(2):e000793. https://doi.org/10.1136/rmdopen-2018-000793.</mixed-citation><mixed-citation xml:lang="en">Tamirou F, Arnaud L, Talarico R, Scirè CA, Alexander T, Amoura Z et al. Systemic lupus erythematosus: state of the art on clinical practice guidelines. RMD Open. 2018;4(2):e000793. https://doi.org/10.1136/rmdopen-2018-000793.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Piga M, Tselios K, Viveiros L, Chessa E, Neves A, Urowitz MB, Isenberg D. Clinical patterns of disease: from early systemic lupus erythematosus to late-onset disease. Best Pract Res Clin Rheumatol. 2023;37(4):101938. https://doi.org/10.1016/j.berh.2024.101938.</mixed-citation><mixed-citation xml:lang="en">Piga M, Tselios K, Viveiros L, Chessa E, Neves A, Urowitz MB, Isenberg D. Clinical patterns of disease: from early systemic lupus erythematosus to late-onset disease. Best Pract Res Clin Rheumatol. 2023;37(4):101938. https://doi.org/10.1016/j.berh.2024.101938.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Kapsala N, Nikolopoulos D, Flouda S, Chavatza A, Tseronis D, Aggelakos M et al. First diagnosis of systemic lupus erythematosus in hospitalized patients: clinical phenotypes and pitfalls for the non-specialist. Am J Med. 2022;135(2):244–253.e3. https://doi.org/10.1016/j.amjmed.2021.07.015.</mixed-citation><mixed-citation xml:lang="en">Kapsala N, Nikolopoulos D, Flouda S, Chavatza A, Tseronis D, Aggelakos M et al. First diagnosis of systemic lupus erythematosus in hospitalized patients: clinical phenotypes and pitfalls for the non-specialist. Am J Med. 2022;135(2):244–253.e3. https://doi.org/10.1016/j.amjmed.2021.07.015.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Bertsias GK, Pamfil C, Fanouriakis A, Boumpas DT. Diagnostic criteria for systemic lupus erythematosus: has the time come? Nat Rev Rheumatol. 2013;9(11):687–694. https://doi.org/10.1038/nrrheum.2013.103.</mixed-citation><mixed-citation xml:lang="en">Bertsias GK, Pamfil C, Fanouriakis A, Boumpas DT. Diagnostic criteria for systemic lupus erythematosus: has the time come? Nat Rev Rheumatol. 2013;9(11):687–694. https://doi.org/10.1038/nrrheum.2013.103.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Bathina A, Chintada DC, Yellu NKR, Vijayashree J, Khatija Begum M, Unnikrishnan P. Clinical and hematological manifestations of systemic lupus erythematosus at initial presentation in a Tertiary Healthcare Center. Cureus. 2024;16(12):e75956. https://doi.org/10.7759/cureus.75956.</mixed-citation><mixed-citation xml:lang="en">Bathina A, Chintada DC, Yellu NKR, Vijayashree J, Khatija Begum M, Unnikrishnan P. Clinical and hematological manifestations of systemic lupus erythematosus at initial presentation in a Tertiary Healthcare Center. Cureus. 2024;16(12):e75956. https://doi.org/10.7759/cureus.75956.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Tharwat S, Husain SM. Musculoskeletal symptoms in systemic lupus erythematosus patients and their impact on health-related quality of life. BMC Musculoskelet Disord. 2024;25(1):272. https://doi.org/10.1186/s12891-024-07367-4.</mixed-citation><mixed-citation xml:lang="en">Tharwat S, Husain SM. Musculoskeletal symptoms in systemic lupus erythematosus patients and their impact on health-related quality of life. BMC Musculoskelet Disord. 2024;25(1):272. https://doi.org/10.1186/s12891-024-07367-4.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Alenzi F, Aljohani R, Aboabat A, Alanazi F, Almalag HM, Omair MA. Systematic review of the reporting of extrarenal manifestations in observational studies of Saudi patients with systemic lupus erythematosus. Lupus Sci Med. 2025;12(1):e001469. https://doi.org/10.1136/lupus-2024-001469.</mixed-citation><mixed-citation xml:lang="en">Alenzi F, Aljohani R, Aboabat A, Alanazi F, Almalag HM, Omair MA. Systematic review of the reporting of extrarenal manifestations in observational studies of Saudi patients with systemic lupus erythematosus. Lupus Sci Med. 2025;12(1):e001469. https://doi.org/10.1136/lupus-2024-001469.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Lahita RG. The clinical presentation of systemic lupus erythematosus. In: Lahita RG (ed.). Systemic Lupus Erythematosus. 5th ed. Elsevier Inc.; 2011, pp. 525–539.</mixed-citation><mixed-citation xml:lang="en">Lahita RG. The clinical presentation of systemic lupus erythematosus. In: Lahita RG (ed.). Systemic Lupus Erythematosus. 5th ed. Elsevier Inc.; 2011, pp. 525–539.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Tselios K, Gladman DD, Touma Z, Su J, Anderson N, Urowitz MB. Disease course patterns in systemic lupus erythematosus. Lupus. 2019;28(1):114–122. https://doi.org/10.1177/0961203318817132.</mixed-citation><mixed-citation xml:lang="en">Tselios K, Gladman DD, Touma Z, Su J, Anderson N, Urowitz MB. Disease course patterns in systemic lupus erythematosus. Lupus. 2019;28(1):114–122.  https://doi.org/10.1177/0961203318817132.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">de Vriese AS, Sethi S, Fervenza FC. Lupus nephritis: redefining the treatment goals. Kidney Int. 2025;107(2):198–211. https://doi.org/10.1016/j.kint.2024.10.018.</mixed-citation><mixed-citation xml:lang="en">de Vriese AS, Sethi S, Fervenza FC. Lupus nephritis: redefining the treatment goals. Kidney Int. 2025;107(2):198–211. https://doi.org/10.1016/j.kint.2024.10.018.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Györi N, Giannakou I, Chatzidionysiou K, Magder L, van Vollenhoven RF, Petri M. Disease activity patterns over time in patients with SLE: analysis of the Hopkins Lupus Cohort. Lupus Sci Med. 2017;4(1):e000192. https://doi.org/10.1136/lupus-2016-000192.</mixed-citation><mixed-citation xml:lang="en">Györi N, Giannakou I, Chatzidionysiou K, Magder L, van Vollenhoven RF, Petri M. Disease activity patterns over time in patients with SLE: analysis of the Hopkins Lupus Cohort. Lupus Sci Med. 2017;4(1):e000192. https://doi.org/10.1136/lupus-2016-000192.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29(2):288–291. Available at: https://pubmed.ncbi.nlm.nih.gov/11838846.</mixed-citation><mixed-citation xml:lang="en">Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29(2):288–291. Available at: https://pubmed.ncbi.nlm.nih.gov/11838846.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Kalunian KC, Merrill JT. Monitoring Disease Activity. In: Lahita RG (ed.). Systemic Lupus Erythematosus. 5th ed. Elsevier Inc.; 2011, pp. 697–705.</mixed-citation><mixed-citation xml:lang="en">Kalunian KC, Merrill JT. Monitoring Disease Activity. In: Lahita RG (ed.). Systemic Lupus Erythematosus. 5th ed. Elsevier Inc.; 2011, pp. 697–705.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Асеева ЕА, Соловьев СК, Насонов ЕЛ. Современные методы оценки активности системной красной волчанки. Научно-практическая ревматология. 2013;51(2):186–200. Режим доступа: https://rsp.mediarpress.net/rsp/article/view/786.</mixed-citation><mixed-citation xml:lang="en">Aseeva EA, Solovyev SK, Nasonov EL. Current methods for evaluating the activity of systemic lupus erythematosus. Rheumatology Science and Practice. 2013;51(2):186–200. (In Russ.) Available at: https://rsp.mediar-press.net/rsp/article/view/786.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Merrill JT. Measuring disease activity. In: Tsokos GC (ed.). Systemic Lupus Erythematosus Basic, Applied and Clinical Aspects. Elsevier Inc.; 2020, pp. 29–35.</mixed-citation><mixed-citation xml:lang="en">Merrill JT. Measuring disease activity. In: Tsokos GC (ed.). Systemic Lupus Erythematosus Basic, Applied and Clinical Aspects. Elsevier Inc.; 2020, pp. 29–35.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Lin A, Wakhlu A, Connelly K. Disease activity assessment in systemic lupus erythematosus. Front Lupus. 2024;2:1442013. https://doi.org/10.3389/flupu.2024.1442013.</mixed-citation><mixed-citation xml:lang="en">Lin A, Wakhlu A, Connelly K. Disease activity assessment in systemic lupus erythematosus. Front Lupus. 2024;2:1442013. https://doi.org/10.3389/flupu.2024.1442013.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Fanouriakis A, Tziolos N, Bertsias G, Boumpas DT. Update οn the diagnosis and management of systemic lupus erythematosus. Ann Rheum Dis. 2021;80(1):14–25. https://doi.org/10.1136/annrheumdis-2020-218272.</mixed-citation><mixed-citation xml:lang="en">Fanouriakis A, Tziolos N, Bertsias G, Boumpas DT. Update οn the diagnosis and management of systemic lupus erythematosus. Ann Rheum Dis. 2021;80(1):14–25.  https://doi.org/10.1136/annrheumdis-2020-218272.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Соловьев СК, Асеева ЕА, Попкова ТВ, Лила АМ, Мазуров ВИ, Насонов ЕЛ. Системная красная волчанка: новые горизонты диагностики и терапии. Научно-практическая ревматология. 2020;58(1):5–14. https://doi.org/10.14412/1995-4484-2020-5-14.</mixed-citation><mixed-citation xml:lang="en">Solovyev SK, Aseeva EA, Popkova TV, Lila AM, Mazurov VI, Nasonov EL. Systemic lupus erythematosus: new horizons for diagnosis and therapy. Rheumatology Science and Practice. 2020;58(1):5–14 (In Russ.) https://doi.org/10.14412/1995-4484-2020-5-14.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Katarzyna PB, Wiktor S, Ewa D, Piotr L. Current treatment of systemic lupus erythematosus: a clinician’s perspective. Rheumatol Int. 2023;43(8):1395–1407. https://doi.org/10.1007/s00296-023-05306-5.</mixed-citation><mixed-citation xml:lang="en">Katarzyna PB, Wiktor S, Ewa D, Piotr L. Current treatment of systemic lupus erythematosus: a clinician’s perspective. Rheumatol Int. 2023;43(8):1395–1407.   https://doi.org/10.1007/s00296-023-05306-5.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Du Toit R, Karamchand S, Doubell AF, Reuter H, Herbst PG. Lupus myocarditis: review of current diagnostic modalities and their application in clinical practice. Rheumatology. 2023;62(2):523–534. https://doi.org/10.1093/rheumatology/keac409.</mixed-citation><mixed-citation xml:lang="en">Du Toit R, Karamchand S, Doubell AF, Reuter H, Herbst PG. Lupus myocarditis: review of current diagnostic modalities and their application in clinical practice. Rheumatology. 2023;62(2):523–534. https://doi.org/10.1093/rheumatology/keac409.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Дядык АИ, Тарадин ГГ, Багрий АЭ. Волчаночный миокардит. Клиническая ревматология. 1997;(1):24–28.</mixed-citation><mixed-citation xml:lang="en">Dyadyk AI, Taradin GG, Bagriy AE. Lupus myocarditis. Klinicheskaja Revmatologija. 1997;(1):24–28. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Wijetunga M, Rockson S. Myocarditis in systemic lupus erythematosus. Am J Med. 2002;113(5):419–423. https://doi.org/10.1016/s0002-9343(02)01223-8.</mixed-citation><mixed-citation xml:lang="en">Wijetunga M, Rockson S. Myocarditis in systemic lupus erythematosus. Am J Med. 2002;113(5):419–423. https://doi.org/10.1016/s0002- 9343(02)01223-8.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Thomas G, Cohen Aubart F, Chiche L, Haroche J, Hié M, Hervier B et al. Lupus myocarditis: initial presentation and longterm outcomes in a multicentric series of 29 patients. J Rheumatol. 2017;44(1):24–32. https://doi.org/10.3899/jrheum.160493.</mixed-citation><mixed-citation xml:lang="en">Thomas G, Cohen Aubart F, Chiche L, Haroche J, Hié M, Hervier B et al. Lupus myocarditis: initial presentation and longterm outcomes in a multicentric series of 29 patients. J Rheumatol. 2017;44(1):24–32. https://doi.org/10.3899/jrheum.160493.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Du Toit R, Herbst PG, van Rensburg A, du Plessis LM, Reuter H, Doubell AF. Clinical features and outcome of lupus myocarditis in the Western Cape, South Africa. Lupus. 2017;26(1):38–47. https://doi.org/10.1177/0961203316651741.</mixed-citation><mixed-citation xml:lang="en">Du Toit R, Herbst PG, van Rensburg A, du Plessis LM, Reuter H, Doubell AF. Clinical features and outcome of lupus myocarditis in the Western Cape, South Africa. Lupus. 2017;26(1):38–47. https://doi.org/10.1177/0961203316651741.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Teixeira RA, Borba EF, Bonfá E, Martinelli Filho M. Arrhythmias in systemic lupus erythematosus. Rev Bras Reumatol. 2010;50(1):81–89. Available at: https://pubmed.ncbi.nlm.nih.gov/21125143.</mixed-citation><mixed-citation xml:lang="en">Teixeira RA, Borba EF, Bonfá E, Martinelli Filho M. Arrhythmias in systemic lupus erythematosus. Rev Bras Reumatol. 2010;50(1):81–89. Available at: https://pubmed.ncbi.nlm.nih.gov/21125143.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Ashour AA, Mansour S, Talal Basrak M, Altermanini M, Sawaf B, Atta MA, Habib MB. Case report: severe sinus tachycardia as a leading manifestation of systemic lupus erythematosus flare. Front Med. 2023;10:1277285. https://doi.org/10.3389/fmed.2023.1277285.</mixed-citation><mixed-citation xml:lang="en">Ashour AA, Mansour S, Talal Basrak M, Altermanini M, Sawaf B, Atta MA, Habib MB. Case report: severe sinus tachycardia as a leading manifestation of systemic lupus erythematosus flare. Front Med. 2023;10:1277285. https://doi.org/10.3389/fmed.2023.1277285.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Gawałko M, Balsam P, Lodziński P, Grabowski M, Krzowski B, Opolski G, Kosiuk J. Cardiac arrhythmias in autoimmune diseases. Circ J. 2020;84(5):685–694. https://doi.org/10.1253/circj.CJ-19-0705.</mixed-citation><mixed-citation xml:lang="en">Gawałko M, Balsam P, Lodziński P, Grabowski M, Krzowski B, Opolski G, Kosiuk J. Cardiac arrhythmias in autoimmune diseases. Circ J. 2020;84(5):685–694.  https://doi.org/10.1253/circj.CJ-19-0705.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Pędzich E, Bednarek A, Młynarska J, Włoszek E, Klimczak-Tomaniak D, Gumiężna K et al. An update on cardiovascular disorders in systemic lupus erythematosus. Adv Clin Exp Med. 2025;34(2):269–281. https://doi.org/10.17219/acem/184868.</mixed-citation><mixed-citation xml:lang="en">Pędzich E, Bednarek A, Młynarska J, Włoszek E, Klimczak-Tomaniak D, Gumiężna K et al. An update on cardiovascular disorders in systemic lupus erythematosus. Adv Clin Exp Med. 2025;34(2):269–281. https://doi.org/10.17219/acem/184868.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Moorani KN, Kashif S. Antiphospholipid syndrome presenting as isolated renal vein thrombosis: a case report and review of the literature. J Med Case Rep. 2025;19(1):123. https://doi.org/10.1186/s13256-025-05117-1.</mixed-citation><mixed-citation xml:lang="en">Moorani KN, Kashif S. Antiphospholipid syndrome presenting as isolated renal vein thrombosis: a case report and review of the literature. J Med Case Rep. 2025;19(1):123. https://doi.org/10.1186/s13256-025-05117-1.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Tektonidou MG. Antiphospholipid syndrome nephropathy: from pathogenesis to treatment. Front Immunol. 2018;9:1181. https://doi.org/10.3389/fimmu.2018.01181.</mixed-citation><mixed-citation xml:lang="en">Tektonidou MG. Antiphospholipid syndrome nephropathy: from pathogenesis to treatment. Front Immunol. 2018;9:1181. https://doi.org/10.3389/fimmu.2018.01181.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Asghar M, Ahmed K, Shah SS, Siddique MK, Dasgupta P, Khan MS. Renal vein thrombosis. Eur J Vasc Endovasc Surg. 2007;34(2):217–223. https://doi.org/10.1016/j.ejvs.2007.02.017.</mixed-citation><mixed-citation xml:lang="en">Asghar M, Ahmed K, Shah SS, Siddique MK, Dasgupta P, Khan MS. Renal vein thrombosis. Eur J Vasc Endovasc Surg. 2007;34(2):217–223. https://doi.org/10.1016/j.ejvs.2007.02.017.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Meroni PL, Chighizola CB, Rovelli F, Gerosa M. Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkers. Arthritis Res Ther. 2014;16(2):209. https://doi.org/10.1186/ar4549.</mixed-citation><mixed-citation xml:lang="en">Meroni PL, Chighizola CB, Rovelli F, Gerosa M. Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkers. Arthritis Res Ther. 2014;16(2):209. https://doi.org/10.1186/ar4549.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">de Azevedo FVA, Maia DG, de Carvalho JF, Rodrigues CEM. Renal involvement in antiphospholipid syndrome. Rheumatol Int. 2018;38(10):1777–1789. https://doi.org/10.1007/s00296-018-4040-2.</mixed-citation><mixed-citation xml:lang="en">de Azevedo FVA, Maia DG, de Carvalho JF, Rodrigues CEM. Renal involvement in antiphospholipid syndrome. Rheumatol Int. 2018;38(10):1777–1789.   https://doi.org/10.1007/s00296-018-4040-2.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Richter P, Badescu MC, Rezus C, Ouatu A, Dima N, Popescu D et al. Antiphospholipid antibodies as key players in systemic lupus erythematosus: the relationship with cytokines and immune dysregulation. Int J Mol Sci. 2024;25(20):11281. https://doi.org/10.3390/ijms252011281.</mixed-citation><mixed-citation xml:lang="en">Richter P, Badescu MC, Rezus C, Ouatu A, Dima N, Popescu D et al. Antiphospholipid antibodies as key players in systemic lupus erythematosus: the relationship with cytokines and immune dysregulation. Int J Mol Sci. 2024;25(20):11281. https://doi.org/10.3390/ijms252011281.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Игнатенко ГА, Тарадин ГГ, Кононенко ЛВ, Ракитская ИВ, Кагитина ЮС, Прендергаст БД. Клапанная болезнь сердца при антифосфолипидном синдроме (обзор литературы). Архивъ внутренней медицины. 2025;15(2): 102–116. https://doi.org/10.20514/2226-6704-2025-15-2-102-116.</mixed-citation><mixed-citation xml:lang="en">Ignatenko GA, Taradin GG, Kononenko LV, Rakitskaya IV, Kagitina YS, Prendergast BD. Valvular heart disease in antiphospholipid syndrome (review). Russian Archive of Internal Medicine. 2025;15(2):102–116. (In Russ.) https://doi.org/10.20514/2226-6704-2025-15-2-102-116.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Боброва ЛА, Козловская НЛ. Тромбоэмболические осложнения нефротического синдрома. Терапевтический архив. 2020;92(6):105–116. https://doi.org/10.26442/00403660.2020.06.000667.</mixed-citation><mixed-citation xml:lang="en">Bobrova LA, Kozlovskaya NL. Thromboembolic complications in nephrotic syndrome. Terapevticheskii Arkhiv. 2020;92(6):105–116. (In Russ.) https://doi.org/10.26442/00403660.2020.06.000667.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Rajakrishna P, Cameron S, Turner N. Nephrotic syndrome. In: Turner N (ed.). Oxford Textbook of Clinical Nephrology. 4th ed. Oxford University Press; 2016, pp. 487–495.</mixed-citation><mixed-citation xml:lang="en">Rajakrishna P, Cameron S, Turner N. Nephrotic syndrome. In: Turner N (ed.). Oxford Textbook of Clinical Nephrology. 4th ed. Oxford University Press; 2016, pp. 487–495.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Vivero F, Gonzalez-Echavarri C, Ruiz-Estevez B, Maderuelo I, RuizIrastorza G. Prevalence and predictors of valvular heart disease in patients with systemic lupus erythematosus. Autoimmun Rev. 2016;15(12):1134–1140. https://doi.org/10.1016/j.autrev.2016.09.007.</mixed-citation><mixed-citation xml:lang="en">Vivero F, Gonzalez-Echavarri C, Ruiz-Estevez B, Maderuelo I, RuizIrastorza G. Prevalence and predictors of valvular heart disease in patients with systemic lupus erythematosus. Autoimmun Rev. 2016;15(12):1134–1140.  https://doi.org/10.1016/j.autrev.2016.09.007.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Roveta A, Parodi EL, Brezzi B, Tunesi F, Zanetti V, Merlotti G et al. Lupus nephritis from pathogenesis to new therapies: an update. Int J Mol Sci. 2024;25(16):8981. https://doi.org/10.3390/ijms25168981.</mixed-citation><mixed-citation xml:lang="en">Roveta A, Parodi EL, Brezzi B, Tunesi F, Zanetti V, Merlotti G et al. Lupus nephritis from pathogenesis to new therapies: an update. Int J Mol Sci. 2024;25(16):8981. https://doi.org/10.3390/ijms25168981.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Соловьев СК, Козловская НЛ, Асеева ЕА, Баранов АА, Никишина НЮ, Насонов ЕЛ. Волчаночный нефрит – современные аспекты диагностики и терапии. Часть I. Научно-практическая ревматология. 2024;62(1):55–64. https://doi.org/10.47360/1995-4484-2024-55-64.</mixed-citation><mixed-citation xml:lang="en">Solovyev SK, Kozlovskaya NL, Aseeva EA, Baranov AA, Nikishina NYu, Nasonov EL. Lupus nephritis – modern aspects of diagnosis and therapy. Part I. Rheumatology Science and Practice. 2024;62(1):55–64. (In Russ.) https://doi.org/10.47360/1995-4484-2024-55-64.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
